Reset filters
  • 13 August 2007

Were host factors or superinfection the key to case of rapid HIV progression?

Read the article
  • 24 July 2007

IAS: Integrase inhibitor raltegravir (MK-0518) potent, durable and more tolerable than efavirenz in treatment-naive at 48 weeks

Read the article
  • 24 July 2007

IAS: Regular viral load testing essential for patients in resource limited settings on NNRTIs, says US resistance expert

Read the article
  • 11 July 2007

Is what we know about transmitted drug resistance just ‘the tip of the iceberg?’

Read the article
  • 10 July 2007

Treatment failure and drug resistance not associated with rapid death or illness in Côte d’Ivoire study

Read the article
  • 6 July 2007

Darunavir superior to lopinavir in 48-week study in treatment-experienced patients

Read the article
  • 4 June 2007

Abacavir hypersensitivity screen as part of drug resistance test possible

Read the article
  • 22 May 2007

HIV resistance mutations common but CXCR4 rare among untreated US gay men

Read the article
  • 1 May 2007

Significant fall in transmitted drug-resistant HIV in UK; may be due to better treatment

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.